Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05069038
Title Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Jairam Krishnamurthy
Indications

Her2-receptor negative breast cancer

Therapies

Palbociclib

Age Groups: adult
Covered Countries USA


No variant requirements are available.